| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
5.00(B) |
| Last
Volume: |
262,995 |
Avg
Vol: |
492,576 |
| 52
Week Range: |
$71.24 - $95.38 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
2,305 |
2,305 |
24,823 |
94,111 |
| Total Sell Value |
$218,975 |
$218,975 |
$2,201,702 |
$7,357,280 |
| Total People Sold |
1 |
1 |
4 |
9 |
| Total Sell Transactions |
1 |
1 |
7 |
34 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Merriman Ronald |
Director |
• • – |
2017-05-22 |
4 |
S |
$40.31 |
$704,519 |
D/D |
(17,471) |
17,807 |
|
- |
|
| Merriman Ronald |
Director |
• • – |
2017-05-22 |
4 |
OE |
$30.50 |
$560,687 |
D/D |
17,471 |
28,160 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2017-05-15 |
4 |
S |
$41.44 |
$355,982 |
D/D |
(8,580) |
22,434 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2017-05-15 |
4 |
OE |
$27.24 |
$233,719 |
D/D |
8,580 |
31,014 |
|
- |
|
| Foote Susan Bartlett |
Director |
• • – |
2017-05-11 |
4 |
S |
$41.78 |
$639,819 |
D/D |
(15,314) |
13,251 |
|
- |
|
| Foote Susan Bartlett |
Director |
• • – |
2017-05-11 |
4 |
OE |
$34.41 |
$542,983 |
D/D |
15,314 |
31,725 |
|
- |
|
| Gelbman Ronald G |
Director |
• • – |
2017-03-24 |
4 |
AS |
$40.00 |
$343,200 |
D/D |
(8,580) |
49,688 |
|
- |
|
| Gelbman Ronald G |
Director |
• • – |
2017-03-24 |
4 |
OE |
$27.24 |
$233,719 |
D/D |
8,580 |
58,268 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2017-03-06 |
4 |
A |
$38.43 |
$187,500 |
D/D |
4,879 |
4,879 |
|
- |
|
| Ryding Neil 122-62-507 |
EVP, Global Manufacturing |
• • – |
2017-01-13 |
4 |
D |
$40.32 |
$133,177 |
D/D |
(3,303) |
16,022 |
|
- |
|
| Gelbman Ronald G |
Director |
• • – |
2016-12-12 |
4 |
S |
$40.30 |
$229,025 |
D/D |
(5,683) |
49,688 |
|
- |
|
| Goldstein Dan |
Chief Accounting Officer |
• • – |
2016-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,350 |
3,747 |
|
- |
|
| Burzik Catherine M |
Director |
• • – |
2016-10-25 |
4 |
A |
$34.21 |
$169,989 |
D/D |
4,969 |
4,969 |
|
- |
|
| Jesse Sandra |
EVP and Chief Legal Officer |
• • – |
2016-10-25 |
4 |
A |
$34.21 |
$112,482 |
D/D |
3,288 |
48,166 |
|
- |
|
| Fusco David |
EVP, Global Human Resources |
• • – |
2016-10-25 |
4 |
A |
$34.21 |
$89,972 |
D/D |
2,630 |
16,867 |
|
- |
|
| Selman Byron |
President, Global Markets |
• • – |
2016-10-25 |
4 |
A |
$34.21 |
$131,230 |
D/D |
3,836 |
23,318 |
|
- |
|
| Ryding Neil 122-62-507 |
EVP, Global Manufacturing |
• • – |
2016-10-25 |
4 |
A |
$34.21 |
$112,482 |
D/D |
3,288 |
17,275 |
|
- |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2016-10-25 |
4 |
A |
$34.21 |
$356,229 |
D/D |
10,413 |
10,413 |
|
- |
|
| Ryding Neil 122-62-507 |
EVP, Global Manufacturing |
• • – |
2016-10-20 |
4 |
S |
$34.16 |
$11,990 |
D/D |
(351) |
19,325 |
|
- |
|
| Merriman Ronald |
Director |
• • – |
2016-08-17 |
4 |
S |
$35.09 |
$152,398 |
D/D |
(4,337) |
17,851 |
|
- |
|
| Foote Susan Bartlett |
Director |
• • – |
2016-08-05 |
4 |
S |
$35.32 |
$519,105 |
D/D |
(14,685) |
22,316 |
|
- |
|
| Foote Susan Bartlett |
Director |
• • – |
2016-08-05 |
4 |
OE |
$27.24 |
$233,719 |
D/D |
8,580 |
24,891 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2016-08-04 |
4 |
B |
$35.00 |
$2,099,754 |
D/D |
60,000 |
105,867 |
2.74 |
- |
|
| Gelbman Ronald G |
Director |
• • – |
2016-07-29 |
4 |
OE |
$29.72 |
$349,448 |
D/D |
11,758 |
66,985 |
|
- |
|
| Gelbman Ronald G |
Director |
• • – |
2016-07-29 |
4 |
D |
$30.09 |
$349,465 |
D/D |
(11,614) |
55,371 |
|
- |
|
1312 Records found
|
|
Page 17 of 53 |
|
|
1.16 (1.21%) 
